Comments

Danaher

Q: What sector and industry does Danaher (DHR) operate in?

Danaher is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.

DHRNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$233.10

00.00%

Pre-Market: 4:22 PM EDT

Danaher (DHR) Forecast

News Earnings Danaher (DHR) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

Danaher (NYSE:DHR) Stock Quotes, Forecast and News Summary

Danaher Stock (NYSE: DHR) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 2.55M
Day Range	- - -
52 Wk Range	207.63 - 281.70
Market Cap	$168.36B
P/E Ratio	43.98
Dividend Yield	0.46%
Exchange	NYSE
RSI	30
Short Interest	0.81%
Days to Cover	1.57

Recent News

Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating

Danaher posts Q3 sales of $5.79 billion, surpassing expectations. 2024 guidance includes bioprocessing revenue decline and Cepheid respiratory sales of $1.7 billion.

Vandana Singh

Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What's Driving Markets Tuesday?

Wall Street traded lower for the second consecutive day on Tuesday, as investor sentiment turned cautious with the U.S. presidential election just two weeks away. Concerns over U.S. fiscal policies and potential shifts in economic direction fueled the pause in risk-taking.

Piero Cingari

Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To Annual Guidance

Danaher posted third-quarter sales of $5.8 billion, surpassing expectations, with growth in life sciences and diagnostics segments, and a 27.5% operating margin.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 2.55M
Day Range	- - -
52 Wk Range	207.63 - 281.70
Market Cap	$168.36B
P/E Ratio	43.98
Dividend Yield	0.46%
Exchange	NYSE
RSI	30
Short Interest	0.81%
Days to Cover	1.57

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Danaher (DHR) stock?

You can purchase shares of Danaher (NYSE:DHR) through any online brokerage.

View our list of the best stock brokerages

Who are Danaher (DHR) competitors?

Other companies in Danaher’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS) and Waters (NYSE:WAT).

What is the forecast, or price target, for Danaher (DHR) stock?

Danaher has a consensus price target of $292.50.

What is the current price for Danaher (DHR)?

The stock price for Danaher (NYSE: DHR) is $233.1 last updated November 20, 2024 at 4:22 PM EST.

Does Danaher (DHR) pay a dividend?

A quarterly cash dividend of 0.27 per share of Class A Common Stock. The quarterly cash dividend was payable on October 25, 2024 to stockholders of record on September 27, 2024.

When is Danaher (NYSE:DHR) reporting earnings?

Danaher’s Q4 earnings are confirmed for Tuesday, January 28, 2025.

Is Danaher (DHR) going to split?

There is no upcoming split for Danaher.

What sector and industry does Danaher (DHR) operate in?

Danaher is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.